Tech Company Financing Transactions
Scout Bio Funding Round
On 4/11/2019, Scout Bio announced $20 million in Series B funding from Companion Fund, RiverVest Venture Partners and Adage Capital Management.
Transaction Overview
Company Name
Announced On
4/11/2019
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
Companion Fund (Lead Investor) (Cindy Cole)
RiverVest Venture Partners (Lead Investor) (Nancy Hong)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 N 18th St. 300
Philadelphia, PA 19103
USA
Philadelphia, PA 19103
USA
Phone
Website
Email Address
Not Recorded
Overview
Scout Bio, a Philadelphia, PA-based biotechnology company focused on innovating pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Heffernan
Chief Financial Officer
Damian Lismore
Vice President
Jodi Hayes
VP - Bus. Development
Samantha Busfield
VP - Bus. Development
Colin Giles
VP - Manufacturing
Jaysson Eicholtz
VP - Product Management
Matthew Wilson
Browse more venture capital transactions:
Prev: 4/11/2019: EdiGene venture capital transaction
Next: 4/11/2019: Re Botanicals venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs